Literature DB >> 24006406

Autophagy in blood cancers: biological role and therapeutic implications.

Alessio Nencioni1, Michele Cea, Fabrizio Montecucco, Valter D Longo, Franco Patrone, Angelo M Carella, Tessa L Holyoake, G Vignir Helgason.   

Abstract

Autophagy is a cell recycling process the molecular apparatus of which has been identified over the past decade. Autophagy allows cells to survive starvation and inhospitable conditions and plays a key role in numerous physiological functions, including hematopoiesis and immune responses. In hematologic malignancies, autophagy can either act as a chemo-resistance mechanism or have tumor suppressive functions, depending on the context. In addition, autophagy is involved in other important aspects of blood cancers as it promotes immune competence and anti-cancer immunity, and may even help enhance patient tolerance to standard treatments. Approaches exploiting autophagy, either to activate or inhibit it, could find broad application in hematologic malignancies and contribute to improved clinical outcomes. These aspects are discussed here together with a brief introduction to the molecular machinery of autophagy and to its role in blood cell physiology.

Entities:  

Mesh:

Year:  2013        PMID: 24006406      PMCID: PMC3762088          DOI: 10.3324/haematol.2012.079061

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  100 in total

1.  Clarithromycin enhances dasatinib-induced cell death in chronic myeloid leukemia cells, by inhibition of late stage autophagy.

Authors:  Lisa Schafranek; Tamara M Leclercq; Deborah L White; Timothy P Hughes
Journal:  Leuk Lymphoma       Date:  2012-07-09

2.  PI3K/p110{delta} is a novel therapeutic target in multiple myeloma.

Authors:  Hiroshi Ikeda; Teru Hideshima; Mariateresa Fulciniti; Giulia Perrone; Naoya Miura; Hiroshi Yasui; Yutaka Okawa; Tanyel Kiziltepe; Loredana Santo; Sonia Vallet; Diana Cristea; Elisabetta Calabrese; Gullu Gorgun; Noopur S Raje; Paul Richardson; Nikhil C Munshi; Brian J Lannutti; Kamal D Puri; Neill A Giese; Kenneth C Anderson
Journal:  Blood       Date:  2010-05-26       Impact factor: 22.113

3.  Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein.

Authors:  Pauline Isakson; Magnar Bjørås; Stig Ove Bøe; Anne Simonsen
Journal:  Blood       Date:  2010-06-23       Impact factor: 22.113

4.  ATRA-induced upregulation of Beclin 1 prolongs the life span of differentiated acute promyelocytic leukemia cells.

Authors:  Aurore Trocoli; Julie Mathieu; Muriel Priault; Josy Reiffers; Sylvie Souquère; Gérard Pierron; Françoise Besançon; Mojgan Djavaheri-Mergny
Journal:  Autophagy       Date:  2011-10-01       Impact factor: 16.016

5.  The anticancer drug imatinib induces cellular autophagy.

Authors:  A Ertmer; V Huber; S Gilch; T Yoshimori; V Erfle; J Duyster; H-P Elsässer; H M Schätzl
Journal:  Leukemia       Date:  2007-03-01       Impact factor: 11.528

6.  Inhibition of autophagy abrogates tumour necrosis factor alpha induced apoptosis in human T-lymphoblastic leukaemic cells.

Authors:  L Jia; R R Dourmashkin; P D Allen; A B Gray; A C Newland; S M Kelsey
Journal:  Br J Haematol       Date:  1997-09       Impact factor: 6.998

Review 7.  Autophagy and aging.

Authors:  David C Rubinsztein; Guillermo Mariño; Guido Kroemer
Journal:  Cell       Date:  2011-09-02       Impact factor: 41.582

8.  Regulation of autophagy by cytoplasmic p53.

Authors:  Ezgi Tasdemir; M Chiara Maiuri; Lorenzo Galluzzi; Ilio Vitale; Mojgan Djavaheri-Mergny; Marcello D'Amelio; Alfredo Criollo; Eugenia Morselli; Changlian Zhu; Francis Harper; Ulf Nannmark; Chrysanthi Samara; Paolo Pinton; José Miguel Vicencio; Rosa Carnuccio; Ute M Moll; Frank Madeo; Patrizia Paterlini-Brechot; Rosario Rizzuto; Gyorgy Szabadkai; Gérard Pierron; Klas Blomgren; Nektarios Tavernarakis; Patrice Codogno; Francesco Cecconi; Guido Kroemer
Journal:  Nat Cell Biol       Date:  2008-05-04       Impact factor: 28.824

9.  Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression.

Authors:  Sebastian Brandhorst; Min Wei; Saewon Hwang; Todd E Morgan; Valter D Longo
Journal:  Exp Gerontol       Date:  2013-02-21       Impact factor: 4.032

10.  Autophagy controls everolimus (RAD001) activity in mantle cell lymphoma.

Authors:  Laia Rosich; Dolors Colomer; Gael Roue
Journal:  Autophagy       Date:  2012-10-18       Impact factor: 16.016

View more
  24 in total

1.  Autophagy is associated with cucurbitacin D-induced apoptosis in human T cell leukemia cells.

Authors:  Tsukasa Nakanishi; Yuan Song; Cuiying He; Duo Wang; Kentaro Morita; Junichi Tsukada; Tamotsu Kanazawa; Yasuhiro Yoshida
Journal:  Med Oncol       Date:  2016-02-25       Impact factor: 3.064

Review 2.  Role of autophagy in megakaryocyte differentiation and platelet formation.

Authors:  Tao You; Qi Wang; Li Zhu
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-04-25

3.  Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia.

Authors:  Xian Zeng; Hui Zhao; Yubin Li; Jiajun Fan; Yun Sun; Shaofei Wang; Ziyu Wang; Ping Song; Dianwen Ju
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

4.  Induction of autophagy is a key component of all-trans-retinoic acid-induced differentiation in leukemia cells and a potential target for pharmacologic modulation.

Authors:  Nina Orfali; Tracey R O'Donovan; Michelle J Nyhan; Adrian Britschgi; Mario P Tschan; Mary R Cahill; Nigel P Mongan; Lorraine J Gudas; Sharon L McKenna
Journal:  Exp Hematol       Date:  2015-05-16       Impact factor: 3.084

5.  Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia.

Authors:  Na Yuan; Lin Song; Suping Zhang; Weiwei Lin; Yan Cao; Fei Xu; Yixuan Fang; Zhen Wang; Han Zhang; Xin Li; Zhijian Wang; Jinyang Cai; Jian Wang; Yi Zhang; Xinliang Mao; Wenli Zhao; Shaoyan Hu; Suning Chen; Jianrong Wang
Journal:  Haematologica       Date:  2014-12-15       Impact factor: 9.941

6.  SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response.

Authors:  Cinzia Bologna; Roberta Buonincontri; Sara Serra; Tiziana Vaisitti; Valentina Audrito; Davide Brusa; Andrea Pagnani; Marta Coscia; Giovanni D'Arena; Elisabetta Mereu; Roberto Piva; Richard R Furman; Davide Rossi; Gianluca Gaidano; Cox Terhorst; Silvia Deaglio
Journal:  J Clin Invest       Date:  2015-11-30       Impact factor: 14.808

7.  Autophagy collaborates with ubiquitination to downregulate oncoprotein E2A/Pbx1 in B-cell acute lymphoblastic leukemia.

Authors:  N Yuan; L Song; W Lin; Y Cao; F Xu; S Liu; A Zhang; Z Wang; X Li; Y Fang; H Zhang; W Zhao; S Hu; J Wang; S Zhang
Journal:  Blood Cancer J       Date:  2015-01-23       Impact factor: 11.037

8.  Arsenic trioxide and resveratrol show synergistic anti-leukemia activity and neutralized cardiotoxicity.

Authors:  Yuhua Fan; Meng Chen; Jia Meng; Lei Yu; Yingfeng Tu; Lin Wan; Kun Fang; Wenliang Zhu
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

9.  EIF2A-dependent translational arrest protects leukemia cells from the energetic stress induced by NAMPT inhibition.

Authors:  Chiara Zucal; Vito G D'Agostino; Antonio Casini; Barbara Mantelli; Natthakan Thongon; Debora Soncini; Irene Caffa; Michele Cea; Alberto Ballestrero; Alessandro Quattrone; Stefano Indraccolo; Alessio Nencioni; Alessandro Provenzani
Journal:  BMC Cancer       Date:  2015-11-05       Impact factor: 4.430

10.  Relationship between triterpenoid anticancer drug resistance, autophagy, and caspase-1 in adult T-cell leukemia.

Authors:  Yuan Song; Cuiying He; Duo Wang; Tsukasa Nakanishi; Kentaro Morita; Junichi Tsukada; Tamotsu Kanazawa; Yasuhiro Yoshida
Journal:  PeerJ       Date:  2016-05-12       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.